LKFT NASDAQ
Lakefront Biotherapeutics N.V.
1W: -0.0%
1M: +1.9%
3M: -3.2%
YTD: +3.2%
$29.37
+0.51 (+1.77%)
Weekly Expected Move ±5.5%
$26
$28
$29
$31
$33
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.9B
52W Range25.68-37.78
Volume270,231
Avg Volume229,076
Beta0.12
Dividend—
Analyst Ratings
Company Info
CEOHenry O. Gosebruch
Employees452
SectorHealthcare
IndustryBiotechnology
IPO Date2005-05-05
Websitelakefrontbio.com
SchaliEnhoevedreef 20 T
Mechelen 2800
BE
Mechelen 2800
BE
32 1 534 29 00
About Lakefront Biotherapeutics N.V.
Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential first-in-class treatments for autoimmune diseases.
Latest News
No recent news
Recent Insider Trades
No insider trades found